| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | EVP, Chief Scientific Officer
1 company
Joseph Y Chang last filed a Form 4 in March 2023, as Chief Scientific Officer at NUS. From March 2015 to March 2023, the filings on record show 0 open-market purchases and 13 sales. Joseph Y Chang's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Joseph Y Chang a strong insider score of 72/100, based on 6 past trades. Over a 12-month horizon, all 6 of those trades were profitable, with an average 12-month return of +33.6%.
At the last filing, the largest reported position was 21,234 shares of NUS. The NUS filings lean toward selling, a net 300,106 shares.
Shares as reported in the last Form 4 for each company; the most recent is from March 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2018 | NUS Nu Skin Enterprises, Inc. | Chief Scientific Officer | Sale+OE | 8,500 | $84.21 | $715,785.00 | -12.5% | |
| Nov 10, 2017 | NUS Nu Skin Enterprises, Inc. | Chief Scientific Officer | Sale+OE | 50,000 | $62.19 | $3,109,570.54 | -48.5% | |
| Mar 4, 2016 | NUS Nu Skin Enterprises, Inc. | Chief Scientific Officer | Sell | 20,000 | $34.21 | $684,200.00 | -31.4% |